These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
310 related articles for article (PubMed ID: 31486032)
1. Insert Stability and In Vivo Testing of MicroRNA-Detargeted Oncolytic Picornaviruses. Schulze AJ Methods Mol Biol; 2020; 2058():77-94. PubMed ID: 31486032 [TBL] [Abstract][Full Text] [Related]
9. Oncolytic Activity of Targeted Picornaviruses Formulated as Synthetic Infectious RNA. Elsedawy NB; Nace RA; Russell SJ; Schulze AJ Mol Ther Oncolytics; 2020 Jun; 17():484-495. PubMed ID: 32529026 [TBL] [Abstract][Full Text] [Related]
10. Advance in herpes simplex viruses for cancer therapy. Liu S; Dai M; You L; Zhao Y Sci China Life Sci; 2013 Apr; 56(4):298-305. PubMed ID: 23564184 [TBL] [Abstract][Full Text] [Related]
12. Enhanced Oncolytic Activities of the Telomerase-Specific Replication-Competent Adenovirus Expressing Short-Hairpin RNA against Dicer. Machitani M; Sakurai F; Wakabayashi K; Tachibana M; Fujiwara T; Mizuguchi H Mol Cancer Ther; 2017 Jan; 16(1):251-259. PubMed ID: 27760834 [TBL] [Abstract][Full Text] [Related]
13. Irradiation enhances the therapeutic effect of the oncolytic adenovirus XVir-N-31 in brain tumor initiating cells. Czolk R; Schwarz N; Koch H; Schötterl S; Wuttke TV; Holm PS; Huber SM; Naumann U Int J Mol Med; 2019 Oct; 44(4):1484-1494. PubMed ID: 31432139 [TBL] [Abstract][Full Text] [Related]
14. Photocontrollable mononegaviruses. Tahara M; Takishima Y; Miyamoto S; Nakatsu Y; Someya K; Sato M; Tani K; Takeda M Proc Natl Acad Sci U S A; 2019 Jun; 116(24):11587-11589. PubMed ID: 31138700 [TBL] [Abstract][Full Text] [Related]
15. Safe and Effective Treatment of Experimental Neuroblastoma and Glioblastoma Using Systemically Delivered Triple MicroRNA-Detargeted Oncolytic Semliki Forest Virus. Ramachandran M; Yu D; Dyczynski M; Baskaran S; Zhang L; Lulla A; Lulla V; Saul S; Nelander S; Dimberg A; Merits A; Leja-Jarblad J; Essand M Clin Cancer Res; 2017 Mar; 23(6):1519-1530. PubMed ID: 27637889 [No Abstract] [Full Text] [Related]
16. An Oncolytic Adenovirus Encoding Decorin and Granulocyte Macrophage Colony Stimulating Factor Inhibits Tumor Growth in a Colorectal Tumor Model by Targeting Pro-Tumorigenic Signals and via Immune Activation. Liu Z; Yang Y; Zhang X; Wang H; Xu W; Wang H; Xiao F; Bai Z; Yao H; Ma X; Jin L; Wu C; Seth P; Zhang Z; Wang L Hum Gene Ther; 2017 Aug; 28(8):667-680. PubMed ID: 28530155 [TBL] [Abstract][Full Text] [Related]
18. Development of Group B Coxsackievirus as an Oncolytic Virus: Opportunities and Challenges. Liu H; Luo H Viruses; 2021 Jun; 13(6):. PubMed ID: 34198859 [TBL] [Abstract][Full Text] [Related]
19. A simplified system for generating oncolytic adenovirus vector carrying one or two transgenes. Hu ZB; Wu CT; Wang H; Zhang QW; Wang L; Wang RL; Lu ZZ; Wang LS Cancer Gene Ther; 2008 Mar; 15(3):173-82. PubMed ID: 18157145 [TBL] [Abstract][Full Text] [Related]
20. Oncolytic tanapoxvirus expressing FliC causes regression of human colorectal cancer xenografts in nude mice. Conrad SJ; El-Aswad M; Kurban E; Jeng D; Tripp BC; Nutting C; Eversole R; Mackenzie C; Essani K J Exp Clin Cancer Res; 2015 Feb; 34(1):19. PubMed ID: 25887490 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]